Lab-on-a-chip Diagnostic Systems Market is expected to reach USD 15.1 billion by 2031

Lab-on-a-chip Diagnostic Systems Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the lab-on-a-chip diagnostic systems market will expand from USD 8.6 billion in 2026 to USD 15.1 billion in 2031 at a CAGR of 11.9% during the forecast period.

The Lab-on-a-Chip (LOC) Diagnostic Systems Market is becoming one of the most revolutionary parts of the larger in vitro diagnostics and microfluidics sector due to the growing need for fast, portable, and affordable diagnostic technologies. Lab-on-a-chip platforms combine various laboratory functions into one tiny chip, allowing complex biochemical tests to be conducted with very small amounts of samples and much shorter turnaround times. As a result, these systems are becoming very popular in areas such as point-of-care diagnostics, infectious disease testing, cancer screening, genetic analysis, and personalized medicine. The market is being propelled by the growing prevalence of chronic and infectious diseases, rising demand for decentralized healthcare solutions, and expanding adoption of precision medicine approaches worldwide.

Request a free sample copy or view the report summary: Lab-on-a-chip Diagnostic Systems Market Report

Lab-on-a-chip Diagnostic Systems Market Report Highlights

• The Reagents & Kits segment is likely to see the most substantial growth in the Lab-on-a-Chip Diagnostic Systems Market primarily because of the ramp-up in diagnostic testing volumes along with a steady demand for consumables in clinical labs, research centers, and point-of-care environments. The persistent use of specialized reagents and assay kits that are compatible with lab-on-a-chip platforms is fueled by the increasing utilization of molecular diagnostics, infectious disease screening, and personalization of medicine. Besides, the segment growth is also gaining pace due to the rising funding for rapid testing technologies and the widening scope of home-based diagnostic applications.

• The Microfluidics segment is expected to grow at the highest rate among the technology segments because it plays a key role in miniaturization, automation, and high-throughput analysis in lab-on-a-chip systems. Microfluidic techniques enable the accurate manipulation of very small volumes of liquids, enhancing the speed, sensitivity, and efficiency of tests. The steadily advancing integrated microfluidic chip design, together with increasing need for portable and decentralized diagnostic solutions, is majorly driving the growth of this segment.

• The point-of-care (POCT) testing segment is expected to grow at the fastest rate over the forecast period. The major reason for the increase in POCT testing is the urgent requirement of rapid and real-time diagnostics in emergency care, home healthcare, and remote clinical settings. The rising burden of infectious diseases, the trend towards decentralized healthcare delivery, and the need for quick clinical decision-making are some of the factors driving the use of lab-on-a-chip systems in point-of-care applications.

• Asia-Pacific is expected to be the fastest-growing region in the Lab-on-a-Chip Diagnostic Systems Market due to rapidly expanding healthcare infrastructure, increasing healthcare expenditures, and rising awareness regarding rapid diagnostic testing.

Lab-on-a-chip Diagnostic Systems Market Growth Drivers and Restraints

Growth Drivers:

• Rising demand for rapid and accurate diagnostics: Increasing need for fast, reliable, and early disease detection is driving adoption of lab-on-a-chip technologies, especially in infectious disease and chronic disease management.

• Growth in point-of-care testing (POCT): Expanding use of decentralized healthcare and home-based testing solutions is significantly driving demand for portable diagnostic platforms. POCT enables diagnostic tests to be conducted right where the patients are being taken care of or very close to that location. This includes places like clinics, emergency departments, ambulances, drugstores, and the patients' homes. In this way, POCT does not require the presence of a central laboratory that is well-equipped.

Restraints:

• High initial development and manufacturing costs: The high cost to develop and manufacture microfluidic-based devices on a large scale comes as one of the major restraints in the Lab-on-a-Chip Diagnostic Systems Market. Creating lab-on-a-chip systems involves advanced engineering skills, use of special materials, precision production techniques, as well as great money input in research and development.

Lab-on-a-chip Diagnostic Systems Market Key Development

• Innovation: In March 2026, Roche officially launched its Global AI Infrastructure Expansion with the addition of a massive AI Factory powered entirely by NVIDIA's latest-grade hardware and software platform. With 2,176 high-performance GPUs housed in facilities throughout the U.S. and across Europe, and integrated into Roche's entire value chain, this infrastructure represents a major step forward in Roche being able to accelerate the development of Diagnostic Solutions and Therapeutic Products.

• Acquisition: In January 2025, an innovative company developing next generation Point of Care platforms for in vitro diagnostics SpinChip Diagnostics ASA announced its acquisition by bioMérieux, a world leader in in vitro diagnostics. The acquisition will result in bioMérieux acquiring 100% of SpinChip and includes a Total Enterprise Value (TEV) of NOK 1,624 million.

Lab-on-a-chip Diagnostic Systems Market Segmentation

Knowledge Sourcing Intelligence has segmented the lab-on-a-chip diagnostic systems market based on product type, technology, application, and region:

Lab-on-a-chip Diagnostic Systems Market, By Product Type

• Instruments

• Reagents & Kits

• Software & Services

Lab-on-a-chip Diagnostic Systems Market, By Technology

• Microfluidics

• Polymerase Chain Reaction (PCR)

• Immunoassays

• Electrophoresis

• Biosensors

Lab-on-a-chip Diagnostic Systems Market, By Application

• Clinical Diagnostics

• Drug Discovery

• Genomics & Proteomics

• Point-of-Care Testing

• Environmental Testing

Lab-on-a-chip Diagnostic Systems Market, By Region

• North America

  • USA

  • Canada

  • Mexico

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Thailand

  • Others

• South America

  • Brazil

  • Argentina

  • Others

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Others

Lab-on-a-chip Diagnostic Systems Market Key Players

• Thermo Fisher Scientific

• Danaher Corporation

• Agilent Technologies

• Bio-Rad Laboratories

• Abbott Laboratories

• PerkinElmer

• Standard BioTools

• Dolomite Microfluidics

• Micronit Microtechnologies

• Fluxergy